AIDS News and Research

RSS

ARCA receives approval to commence enrollment of first therapeutic trial using HIV vaccine candidate

News on the progress of a new trial may give new hope to patients with HIV who are dependent on anti-HIV drugs. The AIDS Research Consortium of Atlanta has received approval to begin enrollment of the first therapeutic trial ever conducted using a promising HIV vaccine candidate from Atlanta-based, GeoVax Inc, a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines.

14 Jun 2010

State round-up: Tenn. lawmakers fail to pass bill to opt out of health care law; Mass. officials continue to study hospital sale

Tennessee lawmakers adjourned the 106th General Assembly early Thursday after failing to pass a bill to opt out of the new federal health care law. ... Both chambers passed the budget -- the only piece of legislation they are constitutionally required to adopt -- last week, but spent the last few days wrangling over issues like the federal health care overhaul.

14 Jun 2010

TIME series examines global health

As part of a special package about global health, TIME magazine visits what is known as "the most malarial town on earth" - Apac, Uganda - and examines global malaria control and efforts to eradicate the disease.

14 Jun 2010

AIDS/LifeCycle event raises $10M to support HIV/AIDS services

More than 2,400 participants in AIDS/LifeCycle arrived at the Veterans Center in Los Angeles today after traveling 545 miles from San Francisco over the past seven days in the world's largest annual HIV/AIDS fundraising event. In its ninth year, the event raised $10 million to support the services of San Francisco AIDS Foundation and the L.A. Gay & Lesbian Center that prevent new HIV infections and care for those living with HIV/AIDS.

14 Jun 2010

BIOTECanada congratulates CPHA on 100 years of leadership in public health

As a community partner of the Canadian Public Health Association, BIOTECanada, on behalf of Canada's biotechnology industry, congratulates the CPHA on 100 years of leadership in public health.

11 Jun 2010

Community-based model of DOT improves HIV patient survival: Researchers

When applied to HIV care, the community-based model of directly observed therapy has no effect on virologic outcomes, but significantly improves patient survival. This is according to researchers at the Johns Hopkins Bloomberg School of Public Health, in collaboration with colleagues at University of Cape Town, South Africa, who conducted the first randomized controlled trial of patient-nominated treatment-supporters providing partial DOT in resource-limited settings.

11 Jun 2010

UNITAID approves plan: Solidarity levy to provide funding for health Millennium Development Goals

At a meeting which ended last night, the Executive Board of UNITAID approved a plan to step up efforts to enlist more countries to apply a solidarity levy on air tickets to provide additional funding for the health Millennium Development Goals. The Board approved a number of resolutions, among them the final phase of the establishment of a medicines patent pool, but a situation of depleting funds raises concerns for the many patients currently being treated by UNITAID.

11 Jun 2010

ViroStatics, Vichem Chemie partner to discover new AV-HALT drugs

ViroStatics, srl, an Italian-US biopharmaceutical company today announced the formation of a strategic partnership with Vichem Chemie of Budapest, Hungary to identify, synthesize, screen, and develop the next generation of AntiViral-HyperActivation Limiting Therapeutics (AV-HALTs) for the treatment of HIV/AIDS and other chronic diseases.

11 Jun 2010

New methodology may help control influenza

Scientists have uncovered the flu's secret formula for effectively evolving within and between host species: balance. The key lies with the flu's unique replication process, which has evolved to produce enough mutations for the virus to spread and adapt to its host environment, but not so many that unwanted genomic mutations lead to the flu's demise (catastrophic mutagenesis).

11 Jun 2010

Innovaro facilitates protein transduction technology licensing between Trojan Technologies, Trojantec

Innovaro, a comprehensive innovation solutions company, is pleased to announce that it has facilitated the completion of a licensing transaction between Trojan Technologies USA, a company recently formed by Verdant Ventures Advisors II, LLC, and Trojantec Ltd, a London and Cyprus based biopharmaceutical company.

11 Jun 2010

U.N. MDG summit draft conclusions call for aid promise follow through, highlight progress and challenges

The draft conclusions for the U.N.'s Millennium Development Goals (MDGs) summit in September, which were distributed to governments last week, call on world leaders to follow through on promises of aid money to help countries reach the benchmarks established in 2000, Reuters reports.

11 Jun 2010

Report urges Canada to increase foreign aid spending for G8 maternal, child health initiative

The coalition Make Poverty History released a report on Wednesday, which praises Canada's spending on food aid and programs aimed at fighting diseases such as HIV/AIDS, tuberculosis and malaria, but it also says Canada should spend more on its maternal and child health G8 initiative, the Canadian Press/CTV News reports.

11 Jun 2010

Gamma interferon wakes-up sleeping stem cells to produce immune system cells to fight invading bacteria

Most of the time, the body's blood-forming (hematopoietic) stem cells remain dormant, with just a few producing blood cells and maintaining a balance among the different types.

10 Jun 2010

Baylor Institute of Immunology Research receives nearly $35M as grants in 2009

Even in an economy that's proved devastating to charitable giving and government grants, the Baylor Institute of Immunology Research (BIIR), a component of Baylor Research Institute (BRI), has managed to buck the trend: BIIR received grants totaling nearly $35 million in 2009.

10 Jun 2010

New findings may help researchers design drugs that can prevent HIV

Researchers at the University of Iowa Carver College of Medicine and University of Nebraska Medical Center have created a three-dimensional picture of an important protein that is involved in how HIV -- the virus responsible for AIDS -- is produced inside human cells. The picture may help researchers design drugs that can prevent HIV from reproducing.

10 Jun 2010

Global Fund releases mid-year results for HIV, TB, malaria

The Global Fund to Fight AIDS, Tuberculosis and Malaria announced mid-year results for HIV and TB treatment as well as for insecticide-treated net distribution, Sify News reports.

10 Jun 2010

First clinical trial among African women to test vaginal ring that prevents HIV transmission

The nonprofit International Partnership for Microbicides today announced the initiation of the first trial among women in Africa testing a vaginal ring containing an antiretroviral drug that could one day be used to prevent HIV transmission during sex. The clinical trial, known as IPM 015, tests the safety and acceptability of an innovative approach that adapts a successful technology from the reproductive health field to give women around the world a tool to protect themselves from HIV infection.

9 Jun 2010

Faith-based HIV-prevention program for African-American women and girls

Developing and evaluating a faith-based, HIV-prevention program for African-American mothers and their daughters is the focus of Dr. Chisina Kapungu's $795,000 career development grant from the National Institute of Mental Health.

9 Jun 2010

Global Fund to Fight AIDS, Tuberculosis and Malaria demonstrates strong progress in prevention, treatment

Today the Global Fund to Fight AIDS, Tuberculosis and Malaria announced its latest prevention and treatment numbers, noting in particular that Global Fund-financed programs have put 2.8 million people on treatment for HIV/AIDS, 7 million people have been treated for tuberculosis and 122 million insecticide-treated nets have been distributed to prevent malaria infection.

9 Jun 2010

Gates Foundation announces 5-year, $1.5 billion commitment for maternal, child health

During the Women Deliver conference on Monday Melinda Gates announced that the Bill & Melinda Gates Foundation "will spend $1.5 billion over the next five years on maternal and child health, family planning and nutrition in developing countries, a pledge that signals a new focus for the foundation known for concentrating on vaccines and AIDS," the Wall Street Journal reports (Jordan, 6/7).

9 Jun 2010

AIDS News and Research

ARCA receives approval to commence enrollment of first therapeutic trial using HIV vaccine candidate

State round-up: Tenn. lawmakers fail to pass bill to opt out of health care law; Mass. officials continue to study hospital sale

TIME series examines global health

AIDS/LifeCycle event raises $10M to support HIV/AIDS services

BIOTECanada congratulates CPHA on 100 years of leadership in public health

Community-based model of DOT improves HIV patient survival: Researchers

UNITAID approves plan: Solidarity levy to provide funding for health Millennium Development Goals

ViroStatics, Vichem Chemie partner to discover new AV-HALT drugs

New methodology may help control influenza

Innovaro facilitates protein transduction technology licensing between Trojan Technologies, Trojantec

U.N. MDG summit draft conclusions call for aid promise follow through, highlight progress and challenges

Report urges Canada to increase foreign aid spending for G8 maternal, child health initiative

Gamma interferon wakes-up sleeping stem cells to produce immune system cells to fight invading bacteria

Baylor Institute of Immunology Research receives nearly $35M as grants in 2009

New findings may help researchers design drugs that can prevent HIV

Global Fund releases mid-year results for HIV, TB, malaria

First clinical trial among African women to test vaginal ring that prevents HIV transmission

Faith-based HIV-prevention program for African-American women and girls

Global Fund to Fight AIDS, Tuberculosis and Malaria demonstrates strong progress in prevention, treatment

Gates Foundation announces 5-year, $1.5 billion commitment for maternal, child health

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News